Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies

Zorana Ferjancica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Filip Bihelovica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Bojan Vulovica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Radomir Matovicc University of Belgrade-Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia

Milena Trmcicb Innovation Centre of the Faculty of Chemistry, Belgrade, Serbia

Aleksandar Jankovicc University of Belgrade-Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia

Milos Pavlovica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Filip Djurkovica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Radivoje Prodanovica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Aleksandra Djurdjevic Djelmasa Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Nevena Kalicaninc University of Belgrade-Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia

Mario Zlatovica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Dusan Sladica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia

Thomas Valletd Institut Pasteur, Center for the Viral Populations and Pathogenesis, Paris, France

Marco Vignuzzid Institut Pasteur, Center for the Viral Populations and Pathogenesis, Paris, France;e A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore

Radomir N. Saicica Faculty of Chemistry, University of Belgrade, Belgrade, Serbia;f Serbian Academy of Sciences and Arts, Belgrade, SerbiaCorrespondence[email protected]

show all

Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date